Alfonso Verdú

892 total citations
29 papers, 554 citations indexed

About

Alfonso Verdú is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Clinical Biochemistry. According to data from OpenAlex, Alfonso Verdú has authored 29 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Pediatrics, Perinatology and Child Health and 6 papers in Clinical Biochemistry. Recurrent topics in Alfonso Verdú's work include Metabolism and Genetic Disorders (6 papers), Neonatal and fetal brain pathology (4 papers) and Epilepsy research and treatment (4 papers). Alfonso Verdú is often cited by papers focused on Metabolism and Genetic Disorders (6 papers), Neonatal and fetal brain pathology (4 papers) and Epilepsy research and treatment (4 papers). Alfonso Verdú collaborates with scholars based in Spain, United States and Netherlands. Alfonso Verdú's co-authors include Carlos Avendaño, J Quero, Kenneth L. Robey, Gary E. Eddey, Pedro Gonzalez‐Alegre, Isabelle Desguerre, Celia Pérez‐Cerdá, Stephen G. Reich, Bastiaan R. Bloem and Hyder A. Jinnah and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and The Journal of Comparative Neurology.

In The Last Decade

Alfonso Verdú

27 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alfonso Verdú Spain 13 287 128 113 100 69 29 554
Naomi Hino‐Fukuyo Japan 17 454 1.6× 45 0.4× 77 0.7× 107 1.1× 91 1.3× 59 901
V. Colamaria Italy 14 105 0.4× 84 0.7× 47 0.4× 165 1.6× 76 1.1× 29 552
Akira Sudo Japan 14 307 1.1× 95 0.7× 43 0.4× 83 0.8× 51 0.7× 35 685
A Martínez-Bermejo Spain 14 274 1.0× 139 1.1× 32 0.3× 146 1.5× 41 0.6× 40 650
M Weissert Switzerland 14 155 0.5× 80 0.6× 222 2.0× 167 1.7× 70 1.0× 20 748
Faruk İncecik Türkiye 14 89 0.3× 71 0.6× 69 0.6× 160 1.6× 65 0.9× 86 587
F. Hanefeld Germany 11 149 0.5× 51 0.4× 48 0.4× 53 0.5× 34 0.5× 22 547
Deirdre Peake United Kingdom 9 147 0.5× 58 0.5× 79 0.7× 83 0.8× 80 1.2× 12 495
Ewa Jamroz Poland 13 241 0.8× 69 0.5× 39 0.3× 83 0.8× 50 0.7× 52 529
Sadataka Houdou Japan 12 154 0.5× 51 0.4× 48 0.4× 190 1.9× 38 0.6× 28 462

Countries citing papers authored by Alfonso Verdú

Since Specialization
Citations

This map shows the geographic impact of Alfonso Verdú's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfonso Verdú with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfonso Verdú more than expected).

Fields of papers citing papers by Alfonso Verdú

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfonso Verdú. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfonso Verdú. The network helps show where Alfonso Verdú may publish in the future.

Co-authorship network of co-authors of Alfonso Verdú

This figure shows the co-authorship network connecting the top 25 collaborators of Alfonso Verdú. A scholar is included among the top collaborators of Alfonso Verdú based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfonso Verdú. Alfonso Verdú is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giráldez, Beatriz G., et al.. (2016). Novel mutation in STXBP1 gene in a patient with non-lesional Ohtahara syndrome. SHILAP Revista de lepidopterología. 31(8). 523–527. 5 indexed citations
2.
Giráldez, Beatriz G., et al.. (2015). Nueva mutación en el gen STXBP1 en un paciente con síndrome de Ohtahara no lesional. Neurología. 31(8). 523–527. 5 indexed citations
4.
Sánchez‐Carpintero, Rocío, et al.. (2014). Uso benzodiacepinas en crisis prolongadas y estado epiléptico en la comunidad. Anales de Pediatría. 81(6). 400.e1–400.e6. 1 indexed citations
5.
Blázquez, Alberto, María Morán, Alfonso Verdú, et al.. (2009). Infantile mitochondrial encephalomyopathy with unusual phenotype caused by a novel BCS1L mutation in an isolated complex III-deficient patient. Neuromuscular Disorders. 19(2). 143–146. 33 indexed citations
6.
Verdú, Alfonso, et al.. (2009). Early infantile epileptic encephalopathy with unusual favourable outcome. Brain and Development. 32(8). 673–676. 5 indexed citations
7.
Verdú, Alfonso, et al.. (2009). Clinical pathways as a healthcare tool: design, implementation and assessment of a clinical pathway for lower-extremity deep venous thrombosis. BMJ Quality & Safety. 18(4). 314–320. 10 indexed citations
8.
López‐Herce, Jesús, et al.. (2007). Varicella encephalopathy in immunocompetent children. Journal of Paediatrics and Child Health. 43(3). 193–195. 2 indexed citations
9.
Verdú, Alfonso, et al.. (2007). Neuroimage Findings in 2-Methyl-3-Hydroxybutyryl-CoA Dehydrogenase Deficiency. Pediatric Neurology. 36(4). 264–267. 18 indexed citations
10.
Jinnah, Hyder A., Jasper E. Visser, James C. Harris, et al.. (2006). Delineation of the motor disorder of Lesch–Nyhan disease. Brain. 129(5). 1201–1217. 171 indexed citations
11.
Verdú, Alfonso, et al.. (2005). Familial Arachnoid Cysts. Pediatric Neurology. 33(2). 146–148. 16 indexed citations
12.
Verdú, Alfonso, et al.. (2001). Basilar artery thrombosis in a child heterozygous for factor V Leiden mutation. Pediatric Neurology. 24(1). 69–71. 18 indexed citations
13.
Pérez‐Cerdá, Celia, B. Merinero, Pilar Rodríguez‐Pombo, et al.. (2000). Potential relationship between genotype and clinical outcome in propionic acidaemia patients. European Journal of Human Genetics. 8(3). 187–194. 56 indexed citations
14.
Verdú, Alfonso, et al.. (1996). An assessment of factors affecting neurological recovery after spinal cord injury with vertebral fracture. Spinal Cord. 34(3). 164–166. 10 indexed citations
15.
Verdú, Alfonso, et al.. (1993). Outcome after vertebral fractures with neurological lesion treated either surgically or conservatively in Spain. Spinal Cord. 31(6). 358–366. 12 indexed citations
16.
Avendaño, Carlos & Alfonso Verdú. (1992). Area 3a in the cat. I. A reevaluation of its location and architecture on the basis of Nissl, myelin, acetylcholinesterase, and cytochrome oxidase staining. The Journal of Comparative Neurology. 321(3). 357–372. 30 indexed citations
17.
Pascual-Castroviejo, I, et al.. (1988). Optic glioma with progressive occlusion of the aqueduct of sylvius in monozygotic twins with neurofibromatosis. Brain and Development. 10(1). 24–29. 15 indexed citations
18.
Verdú, Alfonso, et al.. (1987). Serum CPK–BB Isoenzyme in the Assessment of Brain Damage in Asphyctic Term Infants. Acta Paediatrica. 76(6). 914–918. 24 indexed citations
19.
Verdú, Alfonso, et al.. (1986). Cerebrospinal fluid lactate levels in term infants with perinatal hypoxia. Pediatric Neurology. 2(1). 39–42. 25 indexed citations
20.
Verdú, Alfonso. (1965). Abstraktion und Intuition als Wege zur Wahrheit in Yoga und Zen : ein Beitrag zur Phänomenologie und Metaphysik der nicht-christilichen Mystik.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026